INOVIO Pharmaceuticals
NEWS ALERT

INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults

Press Releases

INOVIO to Participate in December Investor Conferences

Posted on November 18, 2025

INOVIO to Participate in December Investor Conferences

Posted on November 18, 2025

INOVIO Announces Pricing of $25 Million Public Offering

Posted on November 11, 2025

INOVIO Announces Pricing of $25 Million Public Offering

Posted on November 11, 2025

INOVIO Announces Proposed Public Offering

Posted on November 10, 2025

INOVIO Announces Proposed Public Offering

Posted on November 10, 2025

INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Posted on November 10, 2025

INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Posted on November 10, 2025

INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults

Posted on November 3, 2025

INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults

Posted on November 3, 2025

SUBSCRIBE FOR UPDATES FROM INOVIO
Register to receive email alerts for INOVIO press releases

© Copyright 2025 INOVIO Pharmaceuticals. All rights reserved.